Mingliang Qiu

Mr. Mingliang Qiu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2019 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
MQMingliang Qiu
Mingliang Qiu
LMLisha Mo
Lisha Mo
JLJuxiang Li
Juxiang Li
HLHua Liang
Hua Liang
WZWeina Zhu
Weina Zhu
WXWeidong Xu
Weidong Xu

3 December 2021 in Medicine
Verified
Journal Article
Open access
ZXZhong-Bo Xu
Zhong-Bo Xu
XFXin Feng
Xin Feng
WZWei-Na Zhu
Wei-Na Zhu
MQMingliang Qiu
Mingliang Qiu
To better understand the molecular mechanism underlying the pathogenesis of multiple sclerosis (MS), we aimed to identify the key genes and microRNAs (miRNA) associated with MS and analyze their interactions. Differentially expressed genes (DEGs) and miRNAs (DEMs) based on the gene miRNA dataset GSE17846 and mRNA dataset GSE21942 were determined using R software. Next, we performed functional enrichment analysis and constructed a protein–protein interaction network. Data validation was performed to ensure the reliability of hub genes. The miRNA-mRNA regulatory network was constructed. In total, 47 DEMs and 843 DEGs were identified. Protein–protein interaction network analysis identified several hub genes, including JUN, FPR2, AKT1, POLR2L, LYZ, CXCL8, HBB, CST3, CTSZ, and MMP9, especially LYZ and CXCL8. We constructed an miRNA-mRNA regulatory network and found that hsa-miR-142-3p, hsa-miR-107, hsa-miR-140-5p, and hsa-miR-613 were the most important miRNAs. This study reveals some key genes and miRNAs that may be involved in the pathogenesis of MS, providing potential targets for the diagnosis and treatment of MS.

16 January 2020 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
MQMingliang Qiu
Mingliang Qiu
LMLisha Mo
Lisha Mo
JLJuxiang Li
Juxiang Li
HLHua Liang
Hua Liang
WZWeina Zhu
Weina Zhu
WXWeidong Xu
Weidong Xu